Shell Asset Management CO Agenus Inc Transaction History

Shell Asset Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.53 - $0.93 $384 - $674	-725 Reduced 0.83%	86,986 $50,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $55,257 - $99,990	87,711 New	87,711 $73,000
Q1 2021 May 10, 2021	SELL	$2.69 - $5.25 $164,894 - $321,819	-61,299 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$2.29 - $4.24 $1,502 - $2,781	-656 Reduced 1.06%	61,299 $241,000
Q1 2020 May 11, 2020	SELL	$1.92 - $4.39 $1,810 - $4,139	-943 Reduced 1.5%	61,955 $152,000
Q4 2019 Feb 13, 2020	SELL	$2.41 - $4.4 $3,718 - $6,789	-1,543 Reduced 2.39%	62,898 $256,000
Q3 2019 Nov 12, 2019	SELL	$2.17 - $3.14 $1,197 - $1,733	-552 Reduced 0.85%	64,441 $166,000
Q2 2019 Aug 12, 2019	SELL	$2.53 - $3.04 $3,757 - $4,514	-1,485 Reduced 2.23%	64,993 $195,000
Q1 2019 May 09, 2019	BUY	$2.51 - $3.73 $166,859 - $247,962	66,478 New	66,478 $197,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.